Clozapine: Clinical Trials

72 trials of Clozapine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 completed, 12 unknown, 7 recruiting, 6 terminated. 32 Phase 4, 11 Phase 3, 9 Not applicable, 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 432Completed 18, Recruiting 6, Terminated 3, Unknown 3, Active not recruiting 1, Withdrawn 1
Phase 311Completed 4, Terminated 2, Unknown 2, Withdrawn 2, Recruiting 1
Not applicable9Completed 6, Unknown 2, Withdrawn 1
Phase 14Completed 4
Phase 24Completed 3, Unknown 1
Early Phase 12Completed 1, Not yet recruiting 1

Follow Clozapine: new trials by email Literature Review of Clozapine trials Research Report on Clozapine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
[Phase 1] Clozapine, [Phase 1] Aripiprazole, [Phase 1] Amisulpride - Treatment-resistant Schizophrenia
Phase 3RecruitingShanghai Mental Health Center3002026-09-012026-11-05
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
gene therapy, clozapine - Parkinson Disease (PD), Gene Therapy
Early Phase 1Not yet recruitingRuijin Hospital62025-08-012025-07-25
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Phase 4Active not recruitingDr. Stavroula Rakitzi842025-06-042026-05-01
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder
Phase 3TerminatedDr. Inge Winter12025-04-272026-11-05
Biomarkers to Enhance Early Schizophrenia Treatment
aripiprazole, risperidone, clozapine - Schizophenia Disorder
Phase 4RecruitingNorthwell Health1802024-09-042026-07-31
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Clozapine, Second-line Antipsychotics (treatment as usual) - Schizophrenia and Related Disorders, Early Treatment-Resistance
Phase 4RecruitingDr. Inge Winter4182024-08-012025-09-26
Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT
Aripiprazole 10 MG - Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
Phase 4UnknownAll India Institute of Medical Sciences, Bhubaneswar602023-08-202023-07-20
An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine
Clozapine, Antipsychotics,Other (non-Clozapine) - Treatment-resistant Schizophrenia
Phase 4TerminatedOhio State University52023-08-162026-02-25
Observation of Clozapine Treatment Safety in Bipolar Disorder.
Clozapine - Bipolar Disorder
Enrolling by invitationMedical University of Gdansk302023-02-232023-08-25
Characterizing Response to Antipsychotics in Schizophrenia
Olanzapine, Clozapine - Schizophrenia, Schizoaffective Disorder
UnknownThe Royal Ottawa Mental Health Centre402023-01-012023-12-06
Effects of Buspirone Combined With Clozapine
Control group (clozapine, placebo), Low-dose group (buspirone tablets, clozapine), High-dose group (buspirone tablets, clozapine) - Schizophrenia
Early Phase 1CompletedChuanfu Song462022-05-012025-04-02
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Clozapine, treatment as usual - Schizophrenia, Schizoaffective Disorder
Phase 4RecruitingNew York State Psychiatric Institute2802022-03-172026-05-04
CLOZAPINE Response in Biotype-1
clozapine, risperidone - Schizophrenia, Schizoaffective Disorder
Phase 4RecruitingUniversity of Texas Southwestern Medical Center5242022-03-012026-05-11
Biomarkers in Clozapine-responding Schizophrenia
Clozapine - Schizophrenia, Psychosis
Phase 4RecruitingJimmi Nielsen2002021-02-282026-01-20
Pharmacokinetics of Clozapine and Norclozapine and the Effect of Pantoprazole
clozapine, pantoprazole - Healthy Volunteers - Male and Female
Phase 1CompletedUniversiti Sains Malaysia332021-02-062025-12-04
Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18
Clozaril 100 mg (Clozapine), WID-CLZ18 - Schizophrenia
Phase 1CompletedWhanin Pharmaceutical Company332021-01-152023-05-16
SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
Clozapine, MECT, DBS - Treatment-resistant Schizophrenia
Phase 3UnknownShanghai Mental Health Center1622020-12-012020-08-27
Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
Clozapine, haloperidol, pimozide, olanzapine, risperidone, amisulpride - Psychosis, Intellectual Disability
Phase 2UnknownFundación Pública Andaluza para la gestión de la Investigación en Sevilla752020-11-262024-03-20
Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
Clozapine, Olanzapine - Psychosis, Substance Use Disorders
Phase 4UnknownAugusta University1002020-07-012020-03-23
Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database
Clozapine - Lymphoma, Leukemia
UnknownUniversity Hospital, Caen10000002019-03-012019-08-30

Showing 20 of 72. Sign in to see all of them.

Conditions studied

Schizophrenia (52)  ·  Psychotic Disorders (17)  ·  Bipolar Disorder (10)  ·  Schizophrenia, Treatment-Resistant (7)  ·  Marijuana Abuse (3)  ·  Substance-Related Disorders (3)  ·  Aggression (2)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Depressive Disorder, Major (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)  ·  Intellectual Disability (2)  ·  Metabolic Syndrome (2)  ·  Parkinson Disease (2)  ·  Adenoviridae Infections (1)

Sponsors

National Institute of Mental Health (NIMH) (5)  ·  Shanghai Mental Health Center (5)  ·  Centre for Addiction and Mental Health (4)  ·  Dartmouth-Hitchcock Medical Center (3)  ·  Harvard Medical School (HMS and HSDM) (3)  ·  Northwell Health (3)  ·  All India Institute of Medical Sciences, Bhubaneswar (2)  ·  Dr. Inge Winter (2)  ·  Novartis (2)  ·  Anders Fink-Jensen, MD, DMSci (1)  ·  Augusta University (1)  ·  Azur Pharma, Inc (1)  ·  Beersheva Mental Health Center (1)  ·  Canadian Network for Observational Drug Effect Studies, CNODES (1)  ·  Central South University (1)

Countries

United States (28)  ·  Canada (9)  ·  China (8)  ·  Israel (5)  ·  South Korea (4)  ·  Spain (3)  ·  Denmark (2)  ·  Germany (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Brazil (1)  ·  France (1)  ·  Greece (1)  ·  India (1)

Top investigators

Alan I Green, MD (4)  ·  Gary Remington, MD, PhD (2)  ·  Alan Green, MD (1)  ·  Alan I. Green, MD (1)  ·  Alasdair Barr, Ph.D (1)  ·  Alexander Grinshpoon, MD, MHA, PhD (1)  ·  Anatoly Kreinin, MD, Phd (1)  ·  Anders Fink-Jensen, MD, DMSci (1)  ·  Ariel Graff, MD, PhD (1)  ·  Baruch Spivak, MD (1)  ·  Benedicto Crespo Facorro, Professor (1)  ·  Bennett L Leventhal, MD (1)  ·  Bo-Hyun Yoon (1)

Results publications

PMID 10372604, PMID 10492856, PMID 15968344, PMID 16172203, PMID 16380684, PMID 16585434, PMID 16585435, PMID 16633199, PMID 16754835, PMID 16818861, PMID 17151158, PMID 17151159, PMID 17187911, PMID 17909124, PMID 18794642, PMID 19640511, PMID 19837567, PMID 20816031, PMID 20819983, PMID 20868641, PMID 21208584, PMID 21369751, PMID 22000938, PMID 22152404, PMID 22207632, PMID 22290266, PMID 22316567, PMID 23235268, PMID 23682213, PMID 23727135, PMID 24028745, PMID 24030617, PMID 24183751, PMID 24400912, PMID 24524169, PMID 24569099, PMID 24581419, PMID 24581550, PMID 24614374, PMID 24630140, PMID 24726579, PMID 24850369, PMID 24862257, PMID 24949994, PMID 25064681, PMID 25075930, PMID 25157964, PMID 25400359, PMID 25562591, PMID 25567425

NIH funding

R01MH049891 (2), 2015 (1), 2023 (1), N01MH090001 (1), N01MH90001 (1), P01HD026927 (1), R01DA013196 (1), R01DA032533 (1), R01MH052376 (1), R01MH060229 (1), R01MH060390 (1), R01MH120317 (1), R01MH134883 (1)